Active Biotech AB Share Price Other OTC
Equities
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 15.6M 1.48M 114M | Capitalization | 178M 16.9M 1.3B |
---|---|---|---|---|---|
Net income 2024 * | -42M -3.98M -306M | Net income 2025 * | -35M -3.32M -255M | EV / Sales 2024 * | - |
Net Debt 2024 * | 6.5M 616K 47.38M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 11.4 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.39% |
Managers | Title | Age | Since |
---|---|---|---|
Helén Tuvesson
CEO | Chief Executive Officer | 62 | 31/12/97 |
Hans Kolam
DFI | Director of Finance/CFO | 73 | 31/12/99 |
Erik Vahtola
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 22/05/19 |
Director/Board Member | 50 | 31/12/19 | |
Michael Shalmi
CHM | Chairman | 59 | 22/05/19 |
1st Jan change | Capi. | |
---|---|---|
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |